Klivira
Request demo

CompuGroup (Aprima) Dupixent Prior Authorization Automation

Klivira streamlines the CompuGroup (Aprima) Dupixent prior authorization process, integrating directly with your CGM Aprima EMR to reduce manual effort and accelerate approvals.

Managing prior authorizations for high-volume specialty drugs like Dupixent within an ambulatory EHR like CompuGroup (Aprima) presents unique challenges. Revenue cycle teams and prior authorization coordinators face significant administrative burden due to complex payer requirements and the need for detailed clinical documentation. Klivira automates this workflow, ensuring efficiency and compliance for dupilumab prescriptions originating from your Aprima system.

Streamlining Dupixent Prior Authorization Workflows in Aprima

When a clinician places an order for Dupixent (dupilumab) within the CompuGroup (Aprima) EMR, Klivira initiates an automated prior authorization request. Our platform leverages CGM APIs to seamlessly extract necessary patient demographics, clinical documentation, and prescription details directly from Aprima, eliminating the need for manual data entry into separate payer portals or ePA systems. This integration ensures that the initial PA submission is both accurate and timely, minimizing delays inherent in traditional workflows.

Navigating Pharmacy vs. Medical Benefit for Dupixent in Aprima

Dupixent, as an IL-4/IL-13 inhibitor, can fall under either the pharmacy benefit or the medical benefit depending on the payer, site of care, and specific plan design. Klivira’s integration with CompuGroup (Aprima) intelligently identifies the correct benefit pathway based on the prescription details and payer rules. This allows for appropriate submission via NCPDP SCRIPT for pharmacy benefit or X12 278 transactions for medical benefit, ensuring the prior authorization request is routed correctly from the outset.

Automated Clinical Data Extraction from Aprima for Dupixent PAs

Klivira's system is engineered to pull the precise clinical data points required for Dupixent prior authorizations directly from Aprima. This includes relevant ICD-10 diagnosis codes (e.g., for atopic dermatitis, asthma, eosinophilic esophagitis, or chronic rhinosinusitis with nasal polyps), medication history, lab results (such as eosinophil counts), and detailed progress notes. By accessing this information via CGM APIs, Klivira constructs a comprehensive clinical narrative that supports payer medical necessity criteria, reducing the likelihood of denials due to incomplete documentation.

Seamless Specialty Pharmacy Integration from Aprima

Many Dupixent prescriptions require fulfillment through specialty pharmacies. Klivira facilitates a streamlined Aprima specialty pharmacy integration by automating the communication and data transfer required for these complex medications. Once prior authorization is secured, our platform can transmit necessary information to the designated specialty pharmacy, ensuring continuity of care and minimizing the administrative burden on your staff. This integration reduces manual hand-offs and potential errors in the specialty drug fulfillment process.

Enhancing ePA Submission for Dupixent within the Aprima Ecosystem

Klivira acts as your dedicated ePA partner, submitting Dupixent prior authorizations directly to payers or through established clearinghouse connections. Our platform supports industry standards like Da Vinci PAS and leverages secure data exchange protocols to ensure compliance and efficiency. By integrating with your CompuGroup (Aprima) EMR, we transform a historically manual and time-consuming process into an automated workflow, allowing your staff to focus on patient care rather than administrative tasks.

Frequently asked questions

How does Klivira integrate with CompuGroup (Aprima) for Dupixent PAs?

Klivira integrates with CompuGroup (Aprima) via CGM APIs to automatically extract patient demographics, clinical notes, diagnosis codes, and prescription details for Dupixent. This direct integration eliminates manual data entry, ensuring that all necessary information for the prior authorization is accurately captured and submitted without staff intervention.

Can Klivira differentiate between pharmacy and medical benefit for Dupixent in Aprima?

Yes, Klivira is designed to identify whether Dupixent falls under the pharmacy or medical benefit based on the prescription and payer rules. Our system then routes the prior authorization request appropriately, either through NCPDP SCRIPT for pharmacy benefit or X12 278 for medical benefit, directly from the Aprima EMR environment.

What specific data does Klivira pull from Aprima to support Dupixent PAs?

Klivira pulls a comprehensive set of data points from Aprima, including relevant ICD-10 codes for Dupixent's indications (e.g., atopic dermatitis, asthma), medication history, lab results (e.g., eosinophil counts), and detailed clinical documentation from progress notes. This ensures all payer-specific criteria for medical necessity are addressed.

Does Klivira support specialty pharmacy routing for Dupixent prescriptions from Aprima?

Yes, Klivira facilitates seamless specialty pharmacy integration for Dupixent prescriptions originating in Aprima. After a prior authorization is approved, our system can transmit necessary information to the designated specialty pharmacy, streamlining the fulfillment process and reducing manual administrative steps for your team.

Is Klivira's integration with Aprima compliant with healthcare data standards?

Klivira adheres to industry standards and best practices for secure healthcare data exchange, including HIPAA compliance for PHI. Our integration with CompuGroup (Aprima) leverages secure CGM APIs and supports ePA standards like Da Vinci PAS and X12 278, ensuring data integrity and regulatory compliance.

Related coverage

Other aprima prior auth coverage

Ready to automate prior auth for this integration?

See how Klivira automates prior authorizations for your team.

Request a demo